PatrickLWagnerMD
General Surgery • Pittsburgh, PAAHN Cancer Institute, Director of Complex General Surgical Oncology
Dr. Wagner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
314 E North Ave
Pittsburgh, PA 15212Phone+1 412-359-3731Fax+1 412-442-2323
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 2003 - 2010- New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 2006 - 2008
University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2002 - 2006
Harvard Medical SchoolClass of 2002
Certifications & Licensure
VA State Medical License 2012 - 2026
WV State Medical License 2018 - 2025
PA State Medical License 2002 - 2024
NY State Medical License 2005 - 2010- American Board of Pathology Pathology - Anatomic
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Outstanding Resident Mentorship Award Virginia Commonwealth University Department of Surgery, 2017
- Valley Health System “Excellence in Service Award” for Courage 2017
Clinical Trials
- Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer Start of enrollment: 2024 Jan 30
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 45 citationsFibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neck.Friederike Göke, Maike Bode, Alina Franzen, Robert Kirsten, Diane Goltz
Modern Pathology. 2013-04-26 - 79 citationsDefining the current negative appendectomy rate: For whom is preoperative computed tomography making an impact?Patrick L. Wagner, Soumitra R. Eachempati, Kevin Soe, Frederic M. Pieracci, Jian Shou
Surgery. 2008-08-01 - 745 citationsSOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomasAdam J. Bass, Hideo Watanabe, Craig H. Mermel, Soyoung Yu, Sven Perner
Nature Genetics. 2009-11-01
Press Mentions
Michigan Entrepreneur, Cancer Survivor Pledges $1 Million Legacy Gift to Support Research at AHN Cancer InstituteAugust 2nd, 2023
Professional Memberships
- Fellow
- Society of Surgical OncologyMember
- Society for Surgery of the Alimentary TractMember
- United States and Canadian Academy of PathologistsMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
